NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Carolina BioOncology Institute
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly - The Lake Norman Chamber of Commerce recognizes Huntersville Physician Dr. John Powderly for his Commitment and Dedication to the Lake Norman Region - CarolinaBioOncology.org
The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly

 

NewswireToday - /newswire/ - Cornelius, NC, United States, 2019/01/25 - The Lake Norman Chamber of Commerce recognizes Huntersville Physician Dr. John Powderly for his Commitment and Dedication to the Lake Norman Region - CarolinaBioOncology.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

On January 18, 2019, the Lake Norman Chamber of Commerce presented the John R. Cherry Community Award to Dr. John Powderly. This award is named in honor of John R. Cherry, the founder of the Chamber who has also been active in servant leadership for several decades. It is the highest award the Chamber presents to a member who has made a significant contribution to the community and region in civic service.

Dr. John Powderly of Huntersville operates the only independent Phase I Cancer Clinic plus human application lab in the United States. Over the last 13 years, Dr Powderly has provided access to cutting edge cancer treatment for over 3,000 patients through 80 clinical trials. His research on early phase immunotherapy research has led to over 100 publications.

Dr. Powderly had an inspiring message regarding his efforts in cancer treatment and research.

Speaking to the Chamber, he said “I founded Carolina BioOncology Institute in Huntersville in 2005 and have been a proud citizen of the Lake Norman region for many years. My goal was and remains to provide cancer patients access to the latest immunotherapy trials in a warm and caring environment. We are the only independent Phase I cancer research clinic in the US and work with multiple leading biotech partners to develop equipment and processes for the future. I am honored to be recognized with the John R. Cherry community service award. Patients inspire me, and it is my continuing mission to provide rapid access to treatment, without bureaucracy and administrative delays.”

About Carolina BioOncology Institute (CBOI)

Carolina BioOncology Institute (carolinabiooncology.org) was founded by Dr. John Powderly in 2005. With a mission to provide the highest level of comprehensive and quality medical care, the clinic focuses on Phase I clinical trials for immunotherapy-based cancer treatments. CBOI also houses a Human Applications Laboratory, BioCytics, whose goal is to bring personalized cellular immunotherapy cancer medicine to the market.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Carolina BioOncology Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Steve Bradley - CarolinaBioOncology.org 
980-441-1033 bizdev[.]carolinabiooncology.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Carolina BioOncology Institute securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Carolina BioOncology Institute / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries
Rely+On Virkon from LANXESS Effective Against Monkeypox Virus
DSM Completes Acquisition of Prodap
Bruker’s Arxspan Business for Lab Informatics Expands Customer Capabilities by Joining Tetra Partner Network
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-line Monotherapy for Small Cell Lung Cancer
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-oncology Candidates from Marengo’s STAR Platform
SCHOTT Establishes Stand-alone Company for its Pharma Business to Promote Further Growth
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific
BASF Expands World-scale Vitamin A Formulation Plant in Ludwigshafen
Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
Ipsen Receives Positive Opinion in Europe for Dysport® in the Management of Urinary Incontinence in Adults
DSM Acquires Brazil’s Leading Animal Nutrition Technology Company to Boost Precision Services Offering
DSM and the World Food Programme Partner to Improve Nutrition Around the World

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Access Communications Pte Ltd

Visit  Limelon Advertising, Co.





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)